Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yismeilin R. Feliz‐Mosquea"'
Autor:
Manuel U. Ramirez, Kenysha Y. J. Clear, Zipporah Cornelius, Alaa Bawaneh, Yismeilin R. Feliz‐Mosquea, Adam S. Wilson, Alistaire D. Ruggiero, Nildris Cruz‐Diaz, Lihong Shi, Bethany A. Kerr, David R. Soto‐Pantoja, Katherine L. Cook
Publikováno v:
Physiological Reports, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract Anthracyclines are standard‐of‐care chemotherapy for the treatment of triple‐negative breast cancer (TNBC). However, high anthracyclines cumulative doses increase heart failure risk. Designing therapeutic strategies that ameliorate car
Externí odkaz:
https://doaj.org/article/6704b622f0ab41f084bb9b3aacd334eb
Autor:
Yismeilin R. Feliz-Mosquea, Brian M. Westwood, Jasmina Varagic, Rajarshi Guha, Craig J. Thomas, David D. Roberts, Lesley A. Mathews Griner, Qing-Rong Chen, Adam S. Wilson, Giselle C. Meléndez, David R. Soto-Pantoja, Marc Ferrer, Anthony L. Schwartz, Ashley A. Christensen, Katherine L. Cook, Maria J. Merino
Publikováno v:
Breast Cancer Research and Treatment. 172:69-82
BACKGROUND: A perennial challenge in systemic cytotoxic cancer therapy is to eradicate primary tumors and metastatic disease while sparing normal tissue from off-target effects of chemotherapy. Anthracyclines such as doxorubicin are effective chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::580ac19929f095661dffd5c9c1ec3f0c
https://doi.org/10.1007/s10549-018-4884-x
https://doi.org/10.1007/s10549-018-4884-x
Autor:
Ivette J, Suárez-Arroyo, Yismeilin R, Feliz-Mosquea, Juliana, Pérez-Laspiur, Rezina, Arju, Shah, Giashuddin, Gerónimo, Maldonado-Martínez, Luis A, Cubano, Robert J, Schneider, Michelle M, Martínez-Montemayor
Publikováno v:
American journal of cancer research. 6(8)
Inflammatory Breast Cancer (IBC) is the most lethal form of breast cancer with a 35% 5-year survival rate. The accurate and early diagnosis of IBC and the development of targeted therapy against this deadly disease remain a great medical challenge. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c146196f6d257f58e1d97bde6f18b808
https://pubmed.ncbi.nlm.nih.gov/27648361
https://pubmed.ncbi.nlm.nih.gov/27648361
Autor:
Katherine L. Cook, Yismeilin R. Feliz-Mosquea, Adam S. Wilson, David R. Soto-Pantoja, Kenysha Y. J. Clear
Publikováno v:
Cancer Research. 78:449-449
The development of immunotherapy is a major recent advance in clinical oncology. However the majority of patients do not respond and those who do, experience resistance and relapse. Therefore, understanding the molecular mechanisms of immune checkpoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::779f1ecd6539bb8c53335c0439653b9b
https://doi.org/10.1158/1538-7445.am2018-449
https://doi.org/10.1158/1538-7445.am2018-449